NCIt definition : A humanized anti-ganglioside GM2 (GM2) monoclonal antibody with potential antineoplastic
and immunomodulating activities. Upon administration, anti-ganglioside GM2 monoclonal
antibody BIW-8962 may activate an antibody dependent cellular cytotoxicity (ADCC)
against GM2-expressing tumor cells. GM2 is a tumor associated antigen (TAA) overexpressed
on the surface of many cancer cells, such as multiple myeloma (MM) cells and neuroblastoma
cells.;